423
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Polymerized Human Placenta Hemoglobin Given Before Ischemia Protects Rat Heart from Ischemia Reperfusion Injury

, , , , , , & show all
Pages 392-397 | Published online: 09 Nov 2011

REFERENCES

  • Yellon, D.M., Hausenloy, D.J. (2007). Myocardial Reperfusion Injury. N Engl J Med 357:1121–1135.
  • McCord, J.M. (1985). Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med 312:159–163.
  • Jahangir, A., Sagar, S., Terzic A. (2007). Aging and cardioprotection. J Appl Physiol 103:2120–2128.
  • Boengler, K., Schulz, R., Heusch, G. (2009). Loss of cardioprotection with ageing. Cardiovasc Res:cvp033.
  • Li, T., Yu, R., Zhang, H.H., Wang, H., Liang, W.G., Yang, X.M., Yang, C.M. (2006). A method for purification and viral inactivation of human placenta hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 34:175–188.
  • Li, T., Zhang, H.H., Wang, H., Yu, R., Yang, C.M. (2006). Purification and viral inactivation of hemoglobin from human placenta blood. Journal of Biomedical Engineering 23:640–644.
  • Li, T., Li, J., Liu, J., Zhang, P., Wu, W., Zhou, R., Li, G., Zhang, W., Yi, M., Huang, H. (2009). Polymerized placenta hemoglobin attenuates ischemia/reperfusion injury and restores the nitroso-redox balance in isolated rat heart. Free Radical Biology and Medicine 46:397–405.
  • Li, T., Liu, J., Yang, Q., Wu, W., Zhang, P., Yang, J., Li, J., Zhang, W., Yang, C. (2009). Polymerized Placenta Hemoglobin Improves Cardiac Functional Recovery and Reduces Infarction Size of Isolated Rat Heart. Artificial Cells, Blood Substitutes, and Biotechnology: An International Journal 37:48–52.
  • Li, T., Zhang, P., Liu, J., Zhou, R., Li, Q., You, Z., Dian, K. (2010). Protective effects of hemoglobin-based oxygen carrier given to isolated heart during ischemia via attenuation of mitochondrial oxidative damage. Free Radical Biology and Medicine 48:1079–1089.
  • Wu, W., Yang, Q., Li, T., Zhang, P., Zhou, R., Yang, C. (2009). Hemoglobin-based Oxygen Carriers Combined with Anticancer Drugs May Enhance Sensitivity of Radiotherapy and Chemotherapy to Solid Tumors. Artificial Cells, Blood Substitutes and Biotechnology 37:163–165.
  • Standl, T., Freitag, M., Burmeister, M.A., Horn, E.P., Wilhelm, S., Am Esch, JS. (2003). Hemoglobin-based oxygen carrier HBOC-201 provides higher and faster increase in oxygen tension in skeletal muscle of anemic dogs than do stored red blood cells. J Vasc Surg 37:859–865.
  • Klein, HG. (2000). The Prospects for Red-Cell Substitutes. N Engl J Med 342:1666–1668.
  • Wu, W., Li, T., Liu, J., Yang, C. (2011). Pretreatment Before Ischemia Induction with Polymerized Human Placenta Hemoglobin (PolyPHb) Attenuates Ischemia/Reperfusion Injury-induced Myocardial Apoptosis. Artificial Cells, Blood Substitutes and Biotechnology 39:3–6.
  • D’Agnillo, F., Chang, T.M. (1998). Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol 16:667–671.
  • Burmeister, M.A., Rempf, C., Standl, T.G., Rehberg, S., Bartsch-Zwemke, S., Krause, T., Tuszynski, S., Gottschalk, A., Schulte am Esch, J. (2005). Effects of prophylactic or therapeutic application of bovine haemoglobin HBOC-200 on ischaemia-reperfusion injury following acute coronary ligature in rats. Br J Anaesth 95:737–745.
  • Caswell, J.E., Strange, M.B., Rimmer, D.M. 3rd, Gibson MF, Cole P, Lefer DJ. (2005). A novel hemoglobin-based blood substitute protects against myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 288:1796–1801.
  • George, I., Yi, G.H., Schulman, A.R., Morrow, B.T., Cheng, Y., Gu, A., Zhang, G., Oz, M.C., Burkhoff, D., Wang, J. (2006). A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia. Am J Physiol Heart Circ Physiol 291:1126–1137.
  • Jahr, J.S., Nesargi, S.B., Lewis, K., Johnson, C. (2002). Blood Substitutes and Oxygen Therapeutics: An Overview and Current Status. American Journal of Therapeutics 9: 437–443.
  • Winslow, R.M. (2003). Current status of blood substitute research: towards a new paradigm. J Intern Med 253:508–517.
  • Chen, J.Y., Scerbo, M., Kramer, G. (2009). A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics 64:803–813.
  • Natanson, C., Kern, S.J., Lurie, P., Banks, S.M., Wolfe, S.M. Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis. JAMA 2008;299:2304–2312.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.